Dr Miles Behan

Miles William Harcourt BEHAN
BSc(Hons), MB BChir, DM, FRCP(Ed)

I attended medical school at both St Andrews and Cambridge Universities. I went on to complete my medical doctorate in Nottingham, focusing on the role of blood cells in myocardial infarction. My specialist Cardiology training was at St Thomas’ Hospital London and in 2009 I was awarded the Cordis International Interventional Fellowship and spent a year in Adelaide, Australia. In 2011 I was appointed Consultant Cardiologist at the Edinburgh Royal Infirmary.

My specialist interest is percutaneous coronary intervention.


Recent Publications
Behan MW, Haude M, Oldroyd KG, Lansky AJ, James S, Baumbach A. Will this trial change my practice? TOTAL: a randomised trial of thrombus aspiration in ST-elevation myocardial infarction. EuroIntervention. 2015;11:361-3.

Verheye S, Jolicœur M, Behan MW, Pettersson T, Sainsbury P, Hill J, Vrolix M, Agostoni P, Engstrom T, Labinaz M, de Silva R, Schwartz M, Meyten N, Uren NG, Doucet S, Tanguay JF, Lindsay S, Henry T, White CJ, Edelman ER, Banai S. Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina. N Engl J Med 2015; 372:519-527
Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H, Hood S, Owens C, Watkins S, Layland J, Lindsay M, Peat E, Rae A, Behan MW, Sood A, Hillis WS, Mordi I, Mahrous A, Ahmed N, Wilson R, Lasalle L, Généreux P, Ford I, Berry C. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol. 2014;63:2088-98.

Behan MW, Lansky A, Jolly S, Baumbach A. Will this trial change my practice? TASTE - a randomised registry on thrombus aspiration in primary PCI with a 30-day endpoint. EuroIntervention 2014;10:406-407

Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, Yeoh SE, Wallace W, Salter D, Fletcher AM, van Beek EJ, Flapan AD, Uren NG, Behan MW, Cruden NL, Mills NL, Fox KA, Rudd JH, Dweck MR, Newby DE.
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2013;13:61754-7

Carrick D, Behan MW, Foo F, Christie J, Hillis WS, Norrie J, Oldroyd KG, Berry C. Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction. Am J Cardiol. 2013;111:45-50.

Blows LH, Dixon GF, Behan MW, Allen R, Cohen AS, Dickinson K, Furniss S, Hatrick R, Hildick-Smith D, Holmberg S, Hyde JA, Kneale B, Lewis ME, Lloyd G, Patel NR, Pegge N, Signy M, Sulke AN, Trivedi U, Walker DM, de Belder AJ. Prospective peer review of regional percutaneous interventional procedures: a tool for quality control and revalidation. EuroIntervention. 2012;8:939-44.

Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE). Cockburn J, Behan MW, de Belder A, Clayton T, Stables R, Oldroyd K, Curzen N, Hildick-Smith D. Heart. 2012 98:1431-5.

Johnman C, Pell JP, Mackay DF, Behan MW, Slack R, Oldroyd KG, Berry C. Clinical outcomes following radial versus femoral artery access in primary and rescue percutaneous coronary intervention in Scotland: retrospective cohort study of 4534 patients. Heart 2012;98:552-7

Behan MW, Holm NR, Curzen NP, Erglis A, Stables RH, de Belder AJ, Niemelä M, Cooter N, Chew DP, Steigen TJ, Oldroyd KG, Jensen JS, Lassen JF, Thuesen L, Hildick-Smith D. Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the NORDIC Bifurcation Study and the British Bifurcation Coronary Study. Circ Cardiovasc Interv 2011:4:57-64 (selected as one of the top 6 publications from the Circulation group in 2011)